Results of uni- and multivariable analyses in MDS with 1% or more ring sideroblasts and in sideroblastic categories (RARS, RCMD-RS)
Variable . | OS . | CI of disease progression . | ||||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | |||
Univariable analysis . | Multivariable analysis . | Univariable analysis . | Multivariable analysis . | |||
MDS with ≥1% ring sideroblasts | ||||||
SF3B1 mutation | .26 | <.001 | .003 | .27 | .001 | .018 |
Age | 1.02 | .082 | .31 | .98 | .03 | .16 |
Bone marrow blasts* | 1.17 | <.001 | .001 | 1.24 | <.001 | <.001 |
Multilineage dysplasia† | 3.7 | <001 | .22 | 2.91 | .030 | .73 |
RBC transfusion dependency‡ | 1.89 | .02 | .026 | 1.52 | .31 | .87 |
Absolute neutrophil count§ | 2.96 | .015 | .46 | 4.79 | .003 | .48 |
Platelet count§ | 1.76 | .006 | .61 | 1.68 | .038 | .14 |
Karyotype§ | 2.28 | <.001 | .001 | 1.77 | .01 | .29 |
Sideroblastic categories (RARS, RCMD-RS) | ||||||
SF3B1 mutation | 0.25 | .001 | .007 | 0.28 | .032 | .026 |
Age | 1.03 | .11 | .098 | .99 | .11 | .052 |
Bone marrow blasts* | 1.23 | .059 | .89 | 1.18 | .33 | .51 |
Multilineage dysplasia† | 3.06 | .005 | .21 | 2.21 | .17 | .53 |
RBC transfusion dependency‡ | 2.07 | .046 | .085 | 1.36 | .56 | .55 |
Absolute neutrophil count§ | 1.19 | .86 | .77 | 2.77 | .29 | .36 |
Platelet count§ | 2.20 | .011 | .51 | 1.64 | .63 | .39 |
Karyotype§ | 2.11 | .029 | .069 | 1.98 | .085 | .46 |
Variable . | OS . | CI of disease progression . | ||||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | |||
Univariable analysis . | Multivariable analysis . | Univariable analysis . | Multivariable analysis . | |||
MDS with ≥1% ring sideroblasts | ||||||
SF3B1 mutation | .26 | <.001 | .003 | .27 | .001 | .018 |
Age | 1.02 | .082 | .31 | .98 | .03 | .16 |
Bone marrow blasts* | 1.17 | <.001 | .001 | 1.24 | <.001 | <.001 |
Multilineage dysplasia† | 3.7 | <001 | .22 | 2.91 | .030 | .73 |
RBC transfusion dependency‡ | 1.89 | .02 | .026 | 1.52 | .31 | .87 |
Absolute neutrophil count§ | 2.96 | .015 | .46 | 4.79 | .003 | .48 |
Platelet count§ | 1.76 | .006 | .61 | 1.68 | .038 | .14 |
Karyotype§ | 2.28 | <.001 | .001 | 1.77 | .01 | .29 |
Sideroblastic categories (RARS, RCMD-RS) | ||||||
SF3B1 mutation | 0.25 | .001 | .007 | 0.28 | .032 | .026 |
Age | 1.03 | .11 | .098 | .99 | .11 | .052 |
Bone marrow blasts* | 1.23 | .059 | .89 | 1.18 | .33 | .51 |
Multilineage dysplasia† | 3.06 | .005 | .21 | 2.21 | .17 | .53 |
RBC transfusion dependency‡ | 2.07 | .046 | .085 | 1.36 | .56 | .55 |
Absolute neutrophil count§ | 1.19 | .86 | .77 | 2.77 | .29 | .36 |
Platelet count§ | 2.20 | .011 | .51 | 1.64 | .63 | .39 |
Karyotype§ | 2.11 | .029 | .069 | 1.98 | .085 | .46 |
Bone marrow blasts were analyzed as a percentage of bone marrow nuclear cells.9
Multilineage dysplasia was analyzed as uni- vs multilineage dysplasia according to WHO criteria.9
RBC transfusion dependency was defined according to Malcovati et al23 and Such et al.24
Cytogenetic abnormalities, absolute neutrophil count, and platelet count were categorized according to the revised international prognostic scoring system.25